Announcement
31 Aug 2026
In August 2026, the United States announced an agreement with Kyowa Kirin on most-favoured-nation drug pricing and a deferral of Section 232 pharmaceutical tariffs.
Source
Sign in to access
Number of interventions
4
0 certainly harmful
2 likely harmful
2 liberalising
List of interventions
Threads
See all
Liberalising Trade Policy Measures
This Thread tracks liberalising trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
15689
interventions
187
jurisdictions
United States: Drug Pricing Agreements
This Thread tracks the U.S. Administration’s agreements with pharmaceutical companies. It is based on the Executive Order titled “Delivering Most-Favored-Nation (MFN) Prescription Drug Pricing to American Patients.” These agreements include tariff relief measures for pharmaceutical companies in return for their commitments to implement most-favored-nation pricing for their drugs and to invest i...
Published: 11 Nov 2025
93
interventions
2
jurisdictions
Harmful Trade Policy Measures
This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
73860
interventions
193
jurisdictions